130 related articles for article (PubMed ID: 38554330)
41. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
Vestermark LW; Larsen S; Lindeløv B; Bastholt L
Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
[TBL] [Abstract][Full Text] [Related]
42. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
[TBL] [Abstract][Full Text] [Related]
43. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
44. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
Kondziolka D; Patel A; Lunsford LD; Kassam A; Flickinger JC
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):427-34. PubMed ID: 10487566
[TBL] [Abstract][Full Text] [Related]
45. Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer.
Orhan O; Eroglu C; Kaplan B; Ucar K; Altinbas M; Ozkan M; Unal D; Yildiz OG; Soyuer S
J Radiat Res; 2011; 52(2):168-75. PubMed ID: 21343682
[TBL] [Abstract][Full Text] [Related]
46. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
47. Re-irradiation of brain metastases and metastatic spinal cord compression: clinical practice suggestions.
Maranzano E; Trippa F; Pacchiarini D; Chirico L; Basagni ML; Rossi R; Bellavita R; Schiavone C; Italiani M; Muti M
Tumori; 2005; 91(4):325-30. PubMed ID: 16277098
[TBL] [Abstract][Full Text] [Related]
48. A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
Mornex F; Thomas L; Mohr P; Hauschild A; Delaunay MM; Lesimple T; Tilgen W; Bui BN; Guillot B; Ulrich J; Bourdin S; Mousseau M; Cupissol D; Bonneterre ME; De Gislain C; Bensadoun RJ; Clavel M
Melanoma Res; 2003 Feb; 13(1):97-103. PubMed ID: 12569292
[TBL] [Abstract][Full Text] [Related]
49. A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
Alexander BM; Wang M; Yung WK; Fine HA; Donahue BA; Tremont IW; Richards RS; Kerlin KJ; Hartford AC; Curran WJ; Mehta MP
J Neurooncol; 2013 Jan; 111(1):33-9. PubMed ID: 23086432
[TBL] [Abstract][Full Text] [Related]
50. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
[TBL] [Abstract][Full Text] [Related]
51. Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial.
Zhang X; Wang T; Wang CY; Zhao P; Huang B; He L; Song YQ
Trials; 2022 Oct; 23(1):876. PubMed ID: 36242060
[TBL] [Abstract][Full Text] [Related]
52. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
53. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
54. Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer.
Gordinier ME; Dizon DS; Weitzen S; Disilvestro PA; Moore RG; Granai CO
J Palliat Med; 2007 Feb; 10(1):61-6. PubMed ID: 17298255
[TBL] [Abstract][Full Text] [Related]
55. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
56. Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
Chen TW; Dai MS; Tseng LM; Chen SC; Chao TY; Chao TC; Chang YC; Chiu CF; Liu CT; Lin CH; Liu CY; Chen YF; Chang DY; Yu JC; Rau KM; Hsieh YY; Shen SC; Huang SM; Cheng AL; Lu YS
JAMA Oncol; 2024 Mar; 10(3):325-334. PubMed ID: 38127335
[TBL] [Abstract][Full Text] [Related]
57. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
58. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.
Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G
Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
Rusthoven CG; Yamamoto M; Bernhardt D; Smith DE; Gao D; Serizawa T; Yomo S; Aiyama H; Higuchi Y; Shuto T; Akabane A; Sato Y; Niranjan A; Faramand AM; Lunsford LD; McInerney J; Tuanquin LC; Zacharia BE; Chiang V; Singh C; Yu JB; Braunstein S; Mathieu D; Touchette CJ; Lee CC; Yang HC; Aizer AA; Cagney DN; Chan MD; Kondziolka D; Bernstein K; Silverman JS; Grills IS; Siddiqui ZA; Yuan JC; Sheehan JP; Cordeiro D; Nosaki K; Seto T; Deibert CP; Verma V; Day S; Halasz LM; Warnick RE; Trifiletti DM; Palmer JD; Attia A; Li B; Cifarelli CP; Brown PD; Vargo JA; Combs SE; Kessel KA; Rieken S; Patel S; Guckenberger M; Andratschke N; Kavanagh BD; Robin TP
JAMA Oncol; 2020 Jul; 6(7):1028-1037. PubMed ID: 32496550
[TBL] [Abstract][Full Text] [Related]
60. Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study.
Hoang T; Dahlberg SE; Schiller JH; Mehta MP; Fitzgerald TJ; Belinsky SA; Johnson DH
J Clin Oncol; 2012 Feb; 30(6):616-22. PubMed ID: 22271472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
